title: In vivo testing of anti-HIV immunotoxins.
authors.affiliation: Department of Microbiology, Montana State University, Bozeman, MT, USA.
authors.forename: S H
authors.initials: SH
authors.lastname: Pincus
authors.forename: T K
authors.initials: TK
authors.lastname: Marcotte
authors.forename: B M
authors.initials: BM
authors.lastname: Forsyth
authors.forename: H
authors.initials: H
authors.lastname: Fang
mesh_terms: D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal; D002986:Clinical Trials as Topic; D003264:Containment of Biohazards; D018450:Disease Progression; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004797:Enzyme-Linked Immunosorbent Assay; D005098:Exotoxins / Q000009:adverse effects / Q000627:therapeutic use; D016655:HIV Core Protein p24 / Q000032:analysis; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology; D006801:Humans; D000922:Immunotoxins / Q000009:adverse effects / Q000627:therapeutic use*; D016399:Lymphoma, T-Cell / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D023421:Models, Animal; D011828:Radiation Chimera; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012276:Ricin; D013154:Spleen / Q000821:virology; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured / Q000637:transplantation / Q000821:virology
chemical_list: C425963:924-RAC; D019380:Anti-HIV Agents; D000911:Antibodies, Monoclonal; C057689:CD4-Pseudomonas toxin; D005098:Exotoxins; D016655:HIV Core Protein p24; D000922:Immunotoxins; D011994:Recombinant Proteins; D012276:Ricin